A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the role of 3 cycles of irinotecan and cisplatin for patients with limited-stage
small-cell lung cancer who received one course of etoposide and cisplatin plus concurrent
accelerated hyperfractionated thoracic irradiation.